| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.34 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |